ID SAT [Human HNSCC] AC CVCL_3160 SY Sat DR CLO; CLO_0009952 DR ArrayExpress; E-MTAB-3610 DR BioSample; SAMN03472538 DR cancercelllines; CVCL_3160 DR Cell_Model_Passport; SIDM00350 DR Cosmic-CLP; 1299050 DR DepMap; ACH-001641 DR EGA; EGAS00001000978 DR GDSC; 1299050 DR GEO; GSM827190 DR GEO; GSM1670403 DR JCRB; JCRB1027 DR JCRB; NIHS0257 DR LINCS_LDP; LCL-1210 DR PharmacoDB; SAT_1346_2019 DR PRIDE; PXD030304 DR Progenetix; CVCL_3160 DR Wikidata; Q54952126 RX PubMed=10601556; RX PubMed=20215515; RX PubMed=27397505; RX PubMed=30894373; RX PubMed=35839778; CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: COSMIC cell lines project. CC Population: Japanese. CC Characteristics: Established from a nude mouse xenograft. CC Doubling time: 72 hours (PubMed=10601556). CC Microsatellite instability: Stable (MSS) (Sanger). CC Omics: Genomics; DNA methylation analysis. CC Omics: Genomics; Whole exome sequencing. CC Omics: Phenotyping; Drug screening. CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; Microarray. CC Omics: Variations; SNP array analysis. CC Genome ancestry: African=0.32%; Native American=1.29%; East Asian, North=77.72%; East Asian, South=18.87%; South Asian=0%; European, North=1.81%; European, South=0% (PubMed=30894373). CC Discontinued: JCRB; NIHS0257; true. ST Source(s): Cosmic-CLP=1299050; DepMap=ACH-001641; JCRB=JCRB1027 ST Amelogenin: X ST CSF1PO: 11 ST D13S317: 10,12 ST D16S539: 10,12 ST D18S51: 18 ST D21S11: 29,32.1 ST D3S1358: 17 ST D5S818: 13 ST D7S820: 11,12 ST D8S1179: 13,14 ST FGA: 24 ST Penta D: 8,13 ST Penta E: 12 ST TH01: 9 ST TPOX: 9,11 ST vWA: 14,18 DI NCIt; C34447; Head and neck squamous cell carcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 30 // RX PubMed=10601556; DOI=10.3892/ijo.16.1.119; RA Nii, Makoto RA Kayada, Yoshiaki RA Yoshiga, Koji RA Takada, Kazuaki RA Okamoto, Tetsuji RA Yanagihara, Kazuyoshi RT "Suppression of metastasis by tissue inhibitor of metalloproteinase-1 RT in a newly established human oral squamous cell carcinoma cell line."; RL Int. J. Oncol. 16:119-124(2000). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). // RX PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662; RA Rothenberg, S. Michael RA Mohapatra, Gayatry RA Rivera, Miguel N. RA Winokur, Daniel RA Greninger, Patricia RA Nitta, Mai RA Sadow, Peter M. RA Sooriyakumar, Gaya RA Brannigan, Brian W. RA Ulman, Matthew J. RA Perera, Rushika M. RA Wang, Rui RA Tam, Angela RA Ma, Xiao-Jun RA Erlander, Mark RA Sgroi, Dennis C. RA Rocco, James W. RA Lingen, Mark W. RA Cohen, Ezra E.W. RA Louis, David Neil RA Settleman, Jeffrey RA Haber, Daniel Arie RT "A genome-wide screen for microdeletions reveals disruption of RT polarity complex genes in diverse human cancers."; RL Cancer Res. 70:2158-2164(2010). // RX PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469; RA Iorio, Francesco RA Knijnenburg, Theo A. RA Vis, Daniel J. RA Bignell, Graham Robert RA Menden, Michael Patrick RA Schubert, Michael RA Aben, Nanne RA Goncalves, Emanuel RA Barthorpe, Syd RA Lightfoot, Howard RA Cokelaer, Thomas RA Greninger, Patricia RA van Dyk, Ewald RA Chang, Han RA de Silva, Heshani RA Heyn, Holger RA Deng, Xian-Ming RA Egan, Regina K. RA Liu, Qing-Song RA Mironenko, Tatiana RA Mitropoulos, Xeni RA Richardson, Laura RA Wang, Jin-Hua RA Zhang, Ting-Hu RA Moran, Sebastian RA Sayols, Sergi RA Soleimani, Maryam RA Tamborero, David RA Lopez-Bigas, Nuria RA Ross-Macdonald, Petra RA Esteller, Manel RA Gray, Nathanael S. RA Haber, Daniel Arie RA Stratton, Michael Rudolf RA Benes, Cyril Henri RA Wessels, Lodewyk F.A. RA Saez-Rodriguez, Julio RA McDermott, Ultan RA Garnett, Mathew J. RT "A landscape of pharmacogenomic interactions in cancer."; RL Cell 166:740-754(2016). // RX PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775; RA Goncalves, Emanuel RA Poulos, Rebecca C. RA Cai, Zhao-Xiang RA Barthorpe, Syd RA Manda, Srikanth S. RA Lucas, Natasha RA Beck, Alexandra RA Bucio-Noble, Daniel RA Dausmann, Michael RA Hall, Caitlin RA Hecker, Michael RA Koh, Jennifer RA Lightfoot, Howard RA Mahboob, Sadia RA Mali, Iman RA Morris, James RA Richardson, Laura RA Seneviratne, Akila J. RA Shepherd, Rebecca RA Sykes, Erin RA Thomas, Frances RA Valentini, Sara RA Williams, Steven G. RA Wu, Yang-Xiu RA Xavier, Dylan RA MacKenzie, Karen L. RA Hains, Peter G. RA Tully, Brett RA Robinson, Phillip James RA Zhong, Qing RA Garnett, Mathew J. RA Reddel, Roger Robert RT "Pan-cancer proteomic map of 949 human cell lines."; RL Cancer Cell 40:835-849.e8(2022). //